Alterity Therapeutics Ltd
ASX:ATH

Watchlist Manager
Alterity Therapeutics Ltd Logo
Alterity Therapeutics Ltd
ASX:ATH
Watchlist
Price: 0.008 AUD Market Closed
Market Cap: 87m AUD

Operating Margin
Alterity Therapeutics Ltd

-3 185.1%
Current
-132 383.7%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 185.1%
=
Operating Profit
-14.2m
/
Revenue
446.3k

Operating Margin Across Competitors

No Stocks Found

Alterity Therapeutics Ltd
Glance View

Market Cap
87m AUD
Industry
Biotechnology

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. The company is headquartered in Melbourne, Victoria and currently employs 11 full-time employees. The company went IPO on 2000-03-28. The firm focuses on developing disease modifying treatments for neurodegenerative conditions. The firm's lead product candidate, ATH434, is being used for the treatment of various Parkinson's disease, Dementia with lewy bodies (DLB) as well as various forms of atypical Parkinsonism, such as Multiple System Atrophy (MSA). ATH434, is a set of molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The firm also has a drug discovery platform generating chemical to intercede in disease processes.

ATH Intrinsic Value
0.049 AUD
Undervaluation 84%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 185.1%
=
Operating Profit
-14.2m
/
Revenue
446.3k
What is the Operating Margin of Alterity Therapeutics Ltd?

Based on Alterity Therapeutics Ltd's most recent financial statements, the company has Operating Margin of -3 185.1%.

Back to Top